The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy-Reference-Cited by-同舟云学术

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

Published:1999-04 Issue:2 Volume:9 Page:125-138
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Ross Jeffrey S.,Fletcher Jonathan A.

Publisher

Elsevier BV

Subject

Cancer Research

Reference124 articles.

1. Amplification of C-ERB-B2 and aggressive breast tumors;Slamon;Science,1988

2. The neu oncogene: more than a prognostic indicator;De Potter;Hum Pathol,1994

3. Interaction between ERB-receptors and heregulin in breast cancer tumor progression and drug resistance;Lupu;Sem Cancer Biol,1995

4. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/ neu oncogene;Slamon;Science,1987

5. Correlation of c- erb B2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading;Berger;Cancer Res,1988

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER2 positive breast cancer: systematic review and network meta-analysis;Revista Peruana de Medicina Experimental y Salud Pública;2024-05-08

2. Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer;Heart;2023-12-16

3. Feature screening for multiple responses;Journal of Multivariate Analysis;2023-11

4. Companion animals as models for human mammary cancer research;Molecular Diagnostics of Cancer [Working Title];2023-10-31

5. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity;Cell Biology and Toxicology;2023-10-27